CYLD - CYLD lysine 63 deubiquitinase Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101094641
CYLD Products (8)
| mRNA | Protein | Name |
|---|---|---|
| XM_045047262.1 | XP_044903197.1 | ubiquitin carboxyl-terminal hydrolase CYLD isoform X1 |
| XM_045047261.1 | XP_044903196.1 | ubiquitin carboxyl-terminal hydrolase CYLD isoform X1 |
| XM_045047268.1 | XP_044903203.1 | ubiquitin carboxyl-terminal hydrolase CYLD isoform X5 |
| XM_045047264.1 | XP_044903199.1 | ubiquitin carboxyl-terminal hydrolase CYLD isoform X1 |
| XM_045047266.1 | XP_044903201.1 | ubiquitin carboxyl-terminal hydrolase CYLD isoform X3 |
| XM_045047265.1 | XP_044903200.1 | ubiquitin carboxyl-terminal hydrolase CYLD isoform X2 |
| XM_045047267.1 | XP_044903202.1 | ubiquitin carboxyl-terminal hydrolase CYLD isoform X4 |
| XM_045047263.1 | XP_044903198.1 | ubiquitin carboxyl-terminal hydrolase CYLD isoform X1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
ubiquitin carboxyl-terminal hydrolase CYLD |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-176426 | Subquinocin | 99.83% | Phase 4 |
Pre-clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-19704 | Pegcantratinib | Antagonist | / | Unkown |
| HY-RS03433 | CYLD Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17882 | Cyld Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24351 | Cyld Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service